Search

Your search keyword '"Del Borgo, C"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Del Borgo, C" Remove constraint Author: "Del Borgo, C"
134 results on '"Del Borgo, C"'

Search Results

3. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

4. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

5. Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?

6. Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)

7. Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

14. Blood glucose and epicardial adipose tissue at the hospital admission as possible predictors for COVID-19 severity

15. Pandemic influenza H1N1, legionellosis, splenic rupture, and vascular thrombosis: a dangerous cocktail

17. Quantitative ultrasound (QUS) in HIV‐infected patients: a reliable and low‐cost technique for bone health assessment

19. Pulmonary embolism and acute cytomegalovirus infection in an immunocompetent patient

27. Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. Central Italy PRESINT Group

33. ISSQoL: a new questionnaire for evaluating the quality of life of people living with HIV in the HAART era.

35. Home care for persons with AIDS: A case-control study to identify determinants of referral to a hospital-based scheme

37. Evaluation of the utility of serological tests in the diagnosis of candidemia

39. Symptom profile in terminally ill AIDS patients

40. Pandemic influenza H1N1, legionellosis, splenic rupture, and vascular thrombosis: A dangerous cocktail.

41. Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?

42. Memory T Cells Subpopulations in a Cohort of COVID-19 Vaccinated or Recovered Subjects.

43. Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19.

44. Dysregulated Inflammatory Cytokine Levels May Be Useful Markers in a Better Up-Dated Management of COVID-19.

45. Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia.

46. Steroid use in measles: A retrospective cohort study during the 2017 outbreak in tertiary referral center, Rome and Latina, Italy.

47. TB specific intracellular cytokines production in Synovial liquid for diagnosis of tuberculous arthritis.

48. Use of Monoclonal Antibodies in Pregnant Women Infected by COVID-19: A Case Series.

49. Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia.

50. Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use.

Catalog

Books, media, physical & digital resources